These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18191337)

  • 1. [Interest of new biomarkers in cervical precancerous lesion management].
    Dachez R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S152-4. PubMed ID: 18191337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of p16 as a marker for cervical cancer precursor lesions.
    O'Connor DM
    J Low Genit Tract Dis; 2007 Apr; 11(2):67-8. PubMed ID: 17415108
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
    Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
    Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Precancerous and cancerous lesions of the uterine cervix--risks of the morphological diagnostics].
    Marinova P; Rampalova J; Kolnikova G; Ortova S; Frantishek O
    Akush Ginekol (Sofiia); 2010; 49(5):58-64. PubMed ID: 21268404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytological diagnosis of precancerous conditions and carcinoma of the uterine cervix].
    Kubancok J; Vatralová L; Jankyová T; Tekeliaková J; Vartovníková G; Spodniaková A; Lisý A
    Cesk Patol; 1990 Aug; 26(3):152-61. PubMed ID: 2208327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Precancerous cervical lesions during pregnancy: diagnostic and treatment].
    Selleret L; Mathevet P
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S131-8. PubMed ID: 18191339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional biomarkers in cervical precancer: an overview.
    Gupta N; Srinivasan R; Rajwanshi A
    Diagn Cytopathol; 2010 Aug; 38(8):618-23. PubMed ID: 19941372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and therapy of cervical preneoplastic pathology. Analysis of another 5 years of activity in a hospital ambulatory center].
    Sartor V; Spairani L; Martini R
    Ann Ostet Ginecol Med Perinat; 1985; 106(2):87-99. PubMed ID: 4083673
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
    Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
    Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of flow cytometry for biomarker-based cervical cancer cells detection.
    Ling J; Wiederkehr U; Cabiness S; Shroyer KR; Robinson JP
    Diagn Cytopathol; 2008 Feb; 36(2):76-84. PubMed ID: 18181189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diagnostic and follow-up program for patients in the 20-34 year age group with suspicious cervical smears.
    Bjersing L; Holmberg NG; Lundström P; Magnússon SS; Segerbrand E; Angström T
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:78. PubMed ID: 5287134
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines in abnormal findings in cytological studies of the cervix uteri].
    van Vugt PJ
    Ned Tijdschr Geneeskd; 1988 Aug; 132(32):1499-500. PubMed ID: 3173515
    [No Abstract]   [Full Text] [Related]  

  • 15. "The mini-conor," evaluation as a biopsy technique in patients with abnormal cervical cytology.
    Frable WJ; McDonald B; Smith J
    Acta Cytol; 1973; 17(5):410-2. PubMed ID: 4517953
    [No Abstract]   [Full Text] [Related]  

  • 16. Colposcopic biopsy in the diagnosis of carcinoma of the cervix.
    Ortiz R; Newton M; Langlois PL
    Obstet Gynecol; 1969 Sep; 34(3):303-6. PubMed ID: 5805526
    [No Abstract]   [Full Text] [Related]  

  • 17. A protein inhibitor, extracted from Hela cells, which recognises a cell surface protease on preneoplastic cells obtained from cervical smears.
    Steven FS; Johnson J; Eason P
    Anticancer Res; 1993; 13(4):1059-61. PubMed ID: 8352525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of cervical cytology and visual inspection with acetic acid in HIV-positive women.
    Akinwuntan AL; Adesina OA; Okolo CA; Oluwasola OA; Oladokun A; Ifemeje AA; Adewole IF
    J Obstet Gynaecol; 2008 Aug; 28(6):638-41. PubMed ID: 19003664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of precancerous and early cancerous changes in the cervix uteri by spot biopsy and "scaphoid" conization].
    Tsenova A
    Akush Ginekol (Sofiia); 1979; 18(2):107-10. PubMed ID: 474915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biomarkers and uterine cervical cancer. Are they useful for prognosis of cancer and triage of precancerous lesions?].
    Salvat J; Schmidt MH; Vincent-Genod A; Slamani L; Martino A
    Contracept Fertil Sex; 1999; 27(7-8):521-31. PubMed ID: 10495569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.